TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Syra Health Corp. Class A ( (SYRA) ).
On November 14, 2025, Syra Health Corp. held its Annual Meeting of Stockholders where several key decisions were made. All five nominees for the board of directors were elected to serve until the next annual meeting, and the appointment of M&K CPAs, PLLC as the independent accounting firm was ratified. Additionally, amendments to the company’s Certificate of Incorporation were approved, including the removal of automatic conversion of Class B stock upon a stockholder’s death and allowing transfers to family members without conversion.
Spark’s Take on SYRA Stock
According to Spark, TipRanks’ AI Analyst, SYRA is a Neutral.
Syra Health Corp. faces significant challenges with profitability and cash flow, which are reflected in its financial performance score. The technical analysis indicates a bearish trend, and the valuation is unattractive due to negative earnings and lack of dividends. These factors combine to result in a low overall stock score.
To see Spark’s full report on SYRA stock, click here.
More about Syra Health Corp. Class A
Average Trading Volume: 22,315
Technical Sentiment Signal: Sell
Current Market Cap: $799.9K
Learn more about SYRA stock on TipRanks’ Stock Analysis page.